Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HARMONY: Steroid-free, calcineurin inhibitor–reduced immunosuppression after renal transplantation
2007-006516-31Phase 4Completed
- Sponsor
- University Hospital Freiburg
- Start
- Mar 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tacrolimus, mycophenolate mofetil and prednisolone in kidney allograft rejection (3 arms), sponsored by University Hospital Freiburg. Primary endpoints: Biopsy-confirmed acute rejection rate, Severity of acute rejection and 2 more. Started Mar 2008; status: completed.
02
Drugs
tacrolimusmycophenolate mofetilprednisolone
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on 2007-006516-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006516-31.